Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection
2001 ◽
Vol 167
(1)
◽
pp. 424-434
◽
2020 ◽
Vol 9
(2)
◽
pp. 102-105